Biology subjects

Boutet, S. C.

Publications and source records attributed to Boutet, S. C..

4 recordsLinked to original sources

bioRxiv2025

Deep learning-driven morphology analysis enables label-free classification of therapeutic agent- naive versus resistant cancer cells

Therapeutic drug treatments of solid tumors are often undermined by various resistance mechanisms. Identification of drug-resistance phenotypes at the single cell level is challenging because conventional molecular methods are cell-destructive, labor-intensive, and cost-prohibitive. To overcome these challenges, we developed an orthogonal approach to drug-resistance phenotyping, through the use of deep-learning-driven morphology analysis of single, high resolution cell images. Specifically, we trained deep learning-based drug resistance classifiers using cell images from 5 different cell lines that were rendered resistant to 5 different therapeutic agents, using a foundation model framework. With high accuracy, the classifier correctly predicted naive or resistance phenotypes across all cancer types and across all the therapeutic agent types (chemotherapeutic, targeted) tested. These results showed that morphology can capture complex phenotype information in the context of drug treatment. To demonstrate the potential clinical utility of the drug resistance classifier, it was applied to a dissociated tumor biopsy and the resulting phenotype predictions were in close concordance with scRNASeq analysis of the biopsy. Our study highlights the potential of deep-learning-driven morphology analysis to provide complex phenotype information, and ultimately shape oncology drug treatment strategies at the patient-level in a clinical context.

cancer biology↗

bioRxiv2024

Label-Free Melanoma Phenotype Classification Using Artificial Intelligence-Based Morphological Profiling

Melanomas are the deadliest skin cancers, in part due to cellular plasticity and heterogeneity. Intratumoral heterogeneity drives varied mutable phenotypes, specifically "melanocytic" and "mesenchymal" cell states, which result in differential functional properties and drug responses. Definitive and rigorous classification of these phenotypic states has been challenging with conventional biomarker-based methods, and high-parameter molecular methods are cell-destructive, labor-intensive, and time-consuming. To overcome these technical and practical limitations, we utilized label-free artificial intelligence-based morphological profiling to classify live melanoma cells into melanocytic and mesenchymal phenotypes based on high resolution imaging of single cells. To predict the phenotypes of single melanoma cells based on morphology alone, we developed the AI-based Melanoma Phenotype Classifier trained with 19 patient-derived cell lines with known melanocytic or mesenchymal transcriptional profiles. To link phenotypic state with high-dimensional morphological profiles, cells were subjected to genetic and chemical perturbations known to shift phenotypic states. The AI classifier successfully predicted phenotypic shifts which were confirmed by single-cell RNA-Seq (scRNA-Seq). These results demonstrate that correlations between melanoma cell phenotypes and morphological changes are detectable by AI. Additionally, the Melanoma Phenotype Classifier was applied to dissociated tumor biopsy samples and characterization of phenotypic heterogeneity was supported by scRNA-Seq transcriptional profiles. This work establishes a link between cell morphology and melanoma phenotypes, laying the groundwork for the use of a label-free morphology-based method for phenotyping live melanoma cells combined with additional analyses.

cancer biology↗

bioRxiv2023

Artificial intelligence-driven morphology-based enrichment of malignant cells from body fluid

Cell morphology is a fundamental feature used to evaluate patient specimens in pathological analysis. However, traditional cytopathology analysis of patient effusion samples is limited by low tumor cell abundance coupled with high background of non-malignant cells, restricting the ability for downstream molecular and functional analyses to identify actionable therapeutic targets. We applied the Deepcell platform that combines microfluidic sorting, brightfield imaging, and real-time deep learning interpretations based on multi-dimensional morphology to enrich carcinoma cells from malignant effusions without cell staining or labels. Carcinoma cell enrichment was validated with whole genome sequencing and targeted mutation analysis, which showed higher sensitivity for detection of tumor fractions and critical somatic variant mutations that were initially at low-levels or undetectable in pre-sort patient samples. Combined, our study demonstrates the feasibility and added value of supplementing traditional morphology-based cytology with deep learning, multi-dimensional morphology analysis, and microfluidic sorting.

pathology↗

bioRxiv2018

Charting the emergent organotypic landscape of the mammalian gut endoderm at single-cell resolution

To comprehensively delineate the ontogeny of an organ system, we generated 112,217 singlecell transcriptomes representing all endoderm populations within the mouse embryo until midgestation. We employed graph-based approaches to model differentiating cells for spatio-temporal characterization of developmental trajectories. Our analysis reveals the detailed architecture of the emergence of the first (primitive or extra-embryonic) endodermal population and pluripotent epiblast. We uncover an unappreciated relationship between descendants of these lineages, before the onset of gastrulation, suggesting that mixing of extra-embryonic and embryonic endoderm cells occurs more than once during mammalian development. We map the trajectories of endoderm cells as they acquire embryonic versus extra-embryonic fates, and their spatial convergence within the gut endoderm; revealing them to be globally similar but retaining aspects of their lineage history. We observe the regionalized localization of cells along the forming gut tube, reflecting their extra-embryonic or embryonic origin, and their coordinate patterning into organ-specific territories along the anterior-posterior axis.

developmental biology↗